Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 27;12(1):2227510. doi: 10.1080/2162402X.2023.2227510

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

PMC Copyright notice

Figure 3. — Effects of i.P., s.C. and i.V. TL-532 in MBT2-bearing mice. Murine MBT-2 bladder cancer cells were inoculated s.c. into immunocompetent C3H/HeN mice. TL-532 was administered i.P. (380 mg/kg) (a and b), s.c. (380 mg/kg) (c and d) and i.V. (47.3 g/L; 200 µL/h for 1 h) (e and f), thrice a week, up to 10 treatments. Tumor volume (a, c and e) and body weight loss (b, c and f) were routinely assessed.